Health

Healthcare Economist Unbiased Analysis of Today’s Healthcare Issues

  • Consequences of Tariffs on Pharmaceutical Products
    by Jason Shafrin on June 6, 2025 at 1:35 am

    That is the topic of a JMCP Viewpoint by Sean Sullivan, Jens Grueger, Aidan Sullivan, and Scott Ramsey. Some excerpts: The Budget Lab at Yale University projected that a 25% ad valorem tariff would increase medication costs by an “average of around $600 per year per household in the United States.”3 Tariffs can also create supply…

  • Factors That Increase Utilization Management Risk
    by Jason Shafrin on June 4, 2025 at 8:12 pm

    That is the title of a new paper published in the American Journal of Managed Care (AJMC) with co-authors Jacob Fajnor, Shurui Zhang, and Donald Nichols. The abstract is below. Objectives: To (1) develop a metric that quantitatively measures the risk that utilization management (UM) policies pose to patients and (2) measure the relationship between…

  • US Physicians in 2024: More likely to work in larger, multi-specialty, PE-owned practices
    by Jason Shafrin on June 3, 2025 at 8:53 pm

    These are the findings from the American Medical Association’s 2024 Physician Practice Benchmark Survey. Physicians included in the survey include those who practice in the U.S., actively see patients, and have completed residency. Here is what the survey finds: Increasingly, physicians are less likely to work in small practices that they or other physicians own.…

  • Your weekend reading
    by Jason Shafrin on May 31, 2025 at 12:04 am

    A list of interesting articles to checkout as you head to the weekend. How America Built the World’s Most Successful Market for Generic Drugs. Reference Pricing as a Deterrent to Entry. Will Florida Medicaid cover a hospitalization in South Dakota? Will better data rescue value-based care? The return of COVID?

  • ISPOR 2025 Award Winners
    by Jason Shafrin on May 29, 2025 at 9:34 pm

    ISPOR recently released their award winners from their 2025 conference this May. Winners are listed below. I’m excited to announce that my podium presentation “Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection” received an award for the Best General Podium…